Sales & Marketing News | pharmaphorum

News

Falling flu vaccine sales in US stall CSL's Seqirus spinout

CSL says flu vaccination rates in the US are expected to fall 12% to 14% this year, and have scuppered its plan to spin out its vaccines unit Seqirus.

News

Texas sues J&J, Kenvue over Tylenol autism claim

Texas has filed a lawsuit against J&J and Kenvue over the debunked claim that Tylenol causes autism, recently trumpeted by President Trump.

News

Novartis' new drugs outweigh Entresto decline in Q3

Now feeling the impact of generic competition on its top product Entresto in the US, Novartis is still looking for pipeline-building deals, says CEO.

News

Organon CEO resigns over 'improper' contraceptive sales

Organon CEO Kevin Ali has stepped down after an audit found sales of the company's Nexplanon contraceptive implant in the US were inflated.

News

Chugai buys 'Asia lag' firm Renalys for $98m upfront

Chugai Pharma has reached a deal to buy Renalys Pharma, a company set up to bring therapies developed elsewhere to markets in Asia.

News

Black and white image of a man putting his finger to his lips to shush

AZ, Organon fall foul of UK's code on pharma promotion

AstraZeneca and Organon have breached the UK pharma industry's code of practice with promotions for an asthma drug and a contraceptive implant.

Falling flu vaccine sales in US stall CSL's Seqirus spinout

Texas sues J&J, Kenvue over Tylenol autism claim

Novartis' new drugs outweigh Entresto decline in Q3

Organon CEO resigns over 'improper' contraceptive sales

Chugai buys 'Asia lag' firm Renalys for $98m upfront

AZ, Organon fall foul of UK's code on pharma promotion

UK's Mission divests kidney drug to Dimerix for $292m

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks